Impel NeuroPharma Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Impel NeuroPharma Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10415
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders. The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delivery technology, a nasal drug delivery platform that delivers drugs for improved biodistribution. Impel’s products are used for the treatment of pain, depression, bipolar disorder, Alzheimer’s disease, migraine and Parkinson’s disease, among others. The company serves pharmaceutical and biotechnology companies, and premier academic research institutions. Impel is headquartered in Seattle, Washington, the US.

Impel NeuroPharma Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Impel NeuroPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Impel NeuroPharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Impel NeuroPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Impel NeuroPharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Impel NeuroPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Impel NeuroPharma Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Impel NeuroPharma Raises USD21 Million in First Tranche of Series C Financing 10
Impel NeuroPharma Raises USD22.3 Million in Venture Financing 11
Impel NeuroPharma Raises USD0.08 Million in Venture Financing 12
Impel NeuroPharma Raises USD1.1 Million Financing 13
Impel NeuroPharma Raises USD4 Million in First Tranche of Series B Financing 14
Impel Neuropharma Raises US$2.6 Million In Venture Financing 15
Impel Neuropharma Raises US$0.03 Million In Venture Financing 16
Partnerships 17
Impel NeuroPharma and Camargo Pharma Enter into Agreement 17
Impel NeuroPharma Inc – Key Competitors 18
Impel NeuroPharma Inc – Key Employees 19
Impel NeuroPharma Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Strategy And Business Planning 21
Sep 13, 2017: Impel Neuropharma: New Headquarters at 201 Elliott 21
Corporate Communications 22
Nov 07, 2018: Impel NeuroPharma names Ellen A. Lubman as chief business officer 22
Oct 03, 2017: Impel NeuroPharma Board Announces Appointment of Jon Congleton as CEO 23
Mar 03, 2017: Veteran Biotech Executive Timothy S. Nelson Joins Impel’s Board of Directors 24
Other Significant Developments 25
Feb 07, 2017: Impel NeuroPharma Partners with Camargo Pharmaceutical Services for Development Programs 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Impel NeuroPharma Inc, Medical Equipment, Key Facts 2
Impel NeuroPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Impel NeuroPharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Impel NeuroPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Impel NeuroPharma Inc, Deals By Market, 2012 to YTD 2018 8
Impel NeuroPharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Impel NeuroPharma Raises USD21 Million in First Tranche of Series C Financing 10
Impel NeuroPharma Raises USD22.3 Million in Venture Financing 11
Impel NeuroPharma Raises USD0.08 Million in Venture Financing 12
Impel NeuroPharma Raises USD1.1 Million Financing 13
Impel NeuroPharma Raises USD4 Million in First Tranche of Series B Financing 14
Impel Neuropharma Raises US$2.6 Million In Venture Financing 15
Impel Neuropharma Raises US$0.03 Million In Venture Financing 16
Impel NeuroPharma and Camargo Pharma Enter into Agreement 17
Impel NeuroPharma Inc, Key Competitors 18
Impel NeuroPharma Inc, Key Employees 19

List of Figures
Impel NeuroPharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Impel NeuroPharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Impel NeuroPharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Impel NeuroPharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Impel NeuroPharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Impel NeuroPharma Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ana Holdings Inc:企業のM&A・事業提携・投資動向
    Ana Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ana Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Grupo Grana y Montero SAA (GRAMONC1):石油・ガス:M&Aディール及び事業提携情報
    Summary Grupo Grana y Montero SAA (Grana y Montero) is a group company that provides engineering and infrastructure services. The company’s business areas include engineering and construction, infrastructure development, real estate and technical services. It provides engineering procurement and con …
  • Dentsply Sirona, Inc.:企業の戦略・SWOT・財務分析
    Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Daimler AG (DAI):企業の財務・戦略的SWOT分析
    Daimler AG (DAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lactalis Ingredients:企業の戦略・SWOT・財務情報
    Lactalis Ingredients - Strategy, SWOT and Corporate Finance Report Summary Lactalis Ingredients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SSA Marine Inc:企業の戦略的SWOT分析
    SSA Marine Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Telkom SA SOC Limited:戦略・SWOT・企業財務分析
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Reject Shop Ltd (TRS):企業の財務・戦略的SWOT分析
    The Reject Shop Ltd (TRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Timken Company
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • moksha8 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Moksha8 Pharmaceuticals Inc (moksha8) is a drug company that offers therapeutic products. The company manufactures and commercializes products for the treatment of critical diseases. It provides vilazodone HCI for depressive disorder. moksha8’s other products include vilazodone HCL, mirtazap …
  • Fletcher Building Ltd:企業のM&A・事業提携・投資動向
    Fletcher Building Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fletcher Building Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Harsoria Healthcare Pvt Ltd:企業の戦略的SWOT分析
    Harsoria Healthcare Pvt Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Eindec Corporation Ltd (42Z):企業の財務・戦略的SWOT分析
    Eindec Corporation Ltd (42Z) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • California Pizza Kitchen, Inc.
    California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report Summary California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gridsum Holding, Inc. (GSUM):企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Shanghai Electric Group Co Ltd:企業のM&A・事業提携・投資動向
    Shanghai Electric Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shanghai Electric Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Singapore Airlines Ltd:企業の戦略・SWOT・財務情報
    Singapore Airlines Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Airlines Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Valneva SE (VLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Valneva SE (Valneva) is a biotech company that develops lifesaving vaccines. The company’s products include IXIARO, a vaccine indicated for the prevention of Japanese encephalitis; and Dukoral, a vaccine indicated for the prevention of cholera and diarrhea; clostridium difficile, lyme, chiku …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆